{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"T2 Biosystems, Inc."},"Symbol":{"label":"Symbol","value":"TTOO"},"Address":{"label":"Address","value":"101 HARTWELL AVENUE, LEXINGTON, Massachusetts, 02421, United States"},"Phone":{"label":"Phone","value":"+1 781 761-4646"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.t2biosystems.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John J. Sperzel","title":"Chairman, President & Chief Executive Officer"},{"name":"Roger Smith","title":"Senior VP-Science, Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}